Swiss Life Private Equity Partners focuses on asset management and investment consulting, with a particular emphasis on private equity investments. The firm, established in 1999, operates as a subsidiary of Swiss Life Group, leveraging its parent company's extensive financial expertise. While specific investment size details are not provided, their portfolio suggests a diverse range of investments across various sectors and stages.
Notable portfolio companies include Acorda Therapeutics in the pharmaceutical industry, DataBank in the data center and managed services sector, and Enanta Pharmaceuticals in biotechnology. Swiss Life Private Equity Partners likely offers its portfolio companies access to the broader Swiss Life network, providing valuable connections and industry insights. The firm's investment approach appears to span early-stage ventures to more established companies, demonstrating flexibility in their investment strategy.
